JP5590781B2 - 標的核酸比率推定方法 - Google Patents
標的核酸比率推定方法 Download PDFInfo
- Publication number
- JP5590781B2 JP5590781B2 JP2008180412A JP2008180412A JP5590781B2 JP 5590781 B2 JP5590781 B2 JP 5590781B2 JP 2008180412 A JP2008180412 A JP 2008180412A JP 2008180412 A JP2008180412 A JP 2008180412A JP 5590781 B2 JP5590781 B2 JP 5590781B2
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- target nucleic
- ratio
- amount
- primer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108020004707 nucleic acids Proteins 0.000 title claims description 592
- 102000039446 nucleic acids Human genes 0.000 title claims description 592
- 150000007523 nucleic acids Chemical class 0.000 title claims description 592
- 238000000034 method Methods 0.000 title claims description 75
- 238000006243 chemical reaction Methods 0.000 claims description 149
- 230000003321 amplification Effects 0.000 claims description 98
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 98
- 238000003752 polymerase chain reaction Methods 0.000 claims description 84
- 238000012360 testing method Methods 0.000 claims description 64
- 238000001514 detection method Methods 0.000 claims description 63
- 238000002156 mixing Methods 0.000 claims description 53
- 108090000623 proteins and genes Proteins 0.000 claims description 51
- 238000005259 measurement Methods 0.000 claims description 28
- 238000004458 analytical method Methods 0.000 claims description 16
- 239000000126 substance Substances 0.000 claims description 10
- 244000045947 parasite Species 0.000 claims description 9
- 238000002060 fluorescence correlation spectroscopy Methods 0.000 claims description 8
- 238000002875 fluorescence polarization Methods 0.000 claims description 8
- 206010071602 Genetic polymorphism Diseases 0.000 claims description 6
- 101150009057 JAK2 gene Proteins 0.000 claims description 6
- 239000002773 nucleotide Substances 0.000 claims description 5
- 125000003729 nucleotide group Chemical group 0.000 claims description 5
- WEVYNIUIFUYDGI-UHFFFAOYSA-N 3-[6-[4-(trifluoromethoxy)anilino]-4-pyrimidinyl]benzamide Chemical compound NC(=O)C1=CC=CC(C=2N=CN=C(NC=3C=CC(OC(F)(F)F)=CC=3)C=2)=C1 WEVYNIUIFUYDGI-UHFFFAOYSA-N 0.000 claims description 3
- 108020005196 Mitochondrial DNA Proteins 0.000 claims description 3
- 102000009465 Growth Factor Receptors Human genes 0.000 claims description 2
- 108010009202 Growth Factor Receptors Proteins 0.000 claims description 2
- 108700026220 vif Genes Proteins 0.000 claims description 2
- 239000000523 sample Substances 0.000 description 121
- 239000000243 solution Substances 0.000 description 63
- 210000004027 cell Anatomy 0.000 description 28
- 241000196324 Embryophyta Species 0.000 description 21
- 230000035772 mutation Effects 0.000 description 19
- 239000012472 biological sample Substances 0.000 description 11
- 229920006395 saturated elastomer Polymers 0.000 description 11
- 238000012408 PCR amplification Methods 0.000 description 8
- 108020004414 DNA Proteins 0.000 description 6
- 239000012530 fluid Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 210000004881 tumor cell Anatomy 0.000 description 5
- 240000008042 Zea mays Species 0.000 description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- 235000005822 corn Nutrition 0.000 description 4
- 230000000875 corresponding effect Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 238000002372 labelling Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 208000035473 Communicable disease Diseases 0.000 description 3
- 108060006698 EGF receptor Proteins 0.000 description 3
- 102000001301 EGF receptor Human genes 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 238000011088 calibration curve Methods 0.000 description 3
- 230000002860 competitive effect Effects 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 238000012937 correction Methods 0.000 description 3
- 230000002596 correlated effect Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 238000003753 real-time PCR Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 206010069754 Acquired gene mutation Diseases 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 210000003470 mitochondria Anatomy 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 230000003071 parasitic effect Effects 0.000 description 2
- 102000054765 polymorphisms of proteins Human genes 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 230000037439 somatic mutation Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 108700028369 Alleles Proteins 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000997832 Homo sapiens Tyrosine-protein kinase JAK2 Proteins 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108091092878 Microsatellite Proteins 0.000 description 1
- 206010061309 Neoplasm progression Diseases 0.000 description 1
- 208000002151 Pleural effusion Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 102100033444 Tyrosine-protein kinase JAK2 Human genes 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000005100 correlation spectroscopy Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000572 ellipsometry Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 238000010363 gene targeting Methods 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000004880 lymph fluid Anatomy 0.000 description 1
- 238000007403 mPCR Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000001819 pancreatic juice Anatomy 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 230000005751 tumor progression Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008180412A JP5590781B2 (ja) | 2008-07-10 | 2008-07-10 | 標的核酸比率推定方法 |
| US12/498,771 US7846696B2 (en) | 2008-07-10 | 2009-07-07 | Method for estimating target nucleic acid ratio |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008180412A JP5590781B2 (ja) | 2008-07-10 | 2008-07-10 | 標的核酸比率推定方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010017127A JP2010017127A (ja) | 2010-01-28 |
| JP2010017127A5 JP2010017127A5 (enExample) | 2011-06-30 |
| JP5590781B2 true JP5590781B2 (ja) | 2014-09-17 |
Family
ID=41505480
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008180412A Active JP5590781B2 (ja) | 2008-07-10 | 2008-07-10 | 標的核酸比率推定方法 |
Country Status (2)
| Country | Link |
|---|---|
| US (1) | US7846696B2 (enExample) |
| JP (1) | JP5590781B2 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103460026B (zh) | 2011-03-29 | 2015-06-10 | 奥林巴斯株式会社 | 利用单个发光粒子检测的光分析装置、光分析方法以及光分析用计算机程序 |
| WO2012136712A1 (en) * | 2011-04-08 | 2012-10-11 | Deutsches Krebsforschungszentrum | Means and methods for quantifying nucleic acids |
| WO2012141019A1 (ja) | 2011-04-13 | 2012-10-18 | オリンパス株式会社 | 単一発光粒子検出を用いた光分析装置、光分析方法及び光分析用コンピュータプログラム |
| WO2013031377A1 (ja) | 2011-08-30 | 2013-03-07 | オリンパス株式会社 | 単一発光粒子検出を用いた光分析装置、光分析方法及び光分析用コンピュータプログラム |
| EP2816344A4 (en) | 2012-02-17 | 2015-09-23 | Olympus Corp | OPTICAL ANALYSIS DEVICE USING SINGLE PARTICLE DETECTION TECHNIQUE, OPTICAL ANALYSIS METHOD, AND COMPUTER PROGRAM FOR OPTICAL ANALYSIS |
| CN104246479B (zh) * | 2012-04-18 | 2016-10-19 | 奥林巴斯株式会社 | 利用光分析的单个粒子检测装置、单个粒子检测方法以及单个粒子检测用计算机程序 |
| EP3059577A4 (en) | 2013-10-07 | 2017-05-31 | Olympus Corporation | Photometric analysis device employing single light-emitting particle detection, photometric analysis method, and computer program for photometric analysis |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE61148B1 (en) | 1988-03-10 | 1994-10-05 | Ici Plc | Method of detecting nucleotide sequences |
| JP3950546B2 (ja) | 1998-03-30 | 2007-08-01 | 株式会社エスアールエル | 核酸試料混合物中の核酸の種類の比率の測定方法 |
| JP2001245697A (ja) * | 2000-03-08 | 2001-09-11 | Japan Science & Technology Corp | 遺伝子発現定量法 |
| JP4472293B2 (ja) * | 2002-08-27 | 2010-06-02 | 財団法人日本紡績検査協会 | 獣毛繊維製品中の獣毛繊維の混用率鑑定法 |
| WO2004101794A1 (ja) | 2003-05-16 | 2004-11-25 | House Foods Corporation | 食品または食品原材料中の特定植物属の定量的pcr検出法 |
| US20060286558A1 (en) * | 2005-06-15 | 2006-12-21 | Natalia Novoradovskaya | Normalization of samples for amplification reactions |
-
2008
- 2008-07-10 JP JP2008180412A patent/JP5590781B2/ja active Active
-
2009
- 2009-07-07 US US12/498,771 patent/US7846696B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2010017127A (ja) | 2010-01-28 |
| US20100009372A1 (en) | 2010-01-14 |
| US7846696B2 (en) | 2010-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4814479B2 (ja) | リアルタイムで内部標準を用いて遺伝子を定量する方法 | |
| JP4443717B2 (ja) | 被験体の定量方法 | |
| CN110964814B (zh) | 用于核酸序列变异检测的引物、组合物及方法 | |
| JP5590781B2 (ja) | 標的核酸比率推定方法 | |
| US9738924B2 (en) | Method of DNA detection and quantification by single-molecule hybridization and manipulation | |
| US20130078631A1 (en) | Probe, and polymorphism detection method using the same | |
| CN108396060A (zh) | 基于实时荧光定量pcr技术的脊肌萎缩症致病基因smn1拷贝数检测试剂盒及方法 | |
| US9845495B2 (en) | Method and kit for detecting target nucleic acid | |
| CN105624296A (zh) | 基于arms荧光pcr法检测基因多态性的通用型荧光发夹引物 | |
| JP2013090622A (ja) | 多型検出用プローブ、多型検出方法、薬効判定方法及び多型検出用キット | |
| CN113891943A (zh) | 通过毛细管电泳(ce)dna图谱对微卫星进行的比较分析 | |
| CN106939334B (zh) | 一种孕妇血浆中胎儿dna含量的检测方法 | |
| EP3895170B1 (en) | Method for detecting a target analyte in a sample using an s-shaped function for a slope data set | |
| CN113930501A (zh) | 人egfr基因突变的数字pcr检测方法及应用 | |
| WO2016194552A1 (ja) | 複数の標的核酸の検出キット及びそれを用いる検出方法 | |
| KR102276717B1 (ko) | 유전자 검출을 위한 올리고뉴클레오타이드 및 이를 이용한 유전자 검출 방법 | |
| Liu et al. | One-step determination of deletion mutation based on loop-mediated isothermal amplification | |
| US9121051B2 (en) | Method of determining the abundance of a target nucleotide sequence of a gene of interest | |
| Wang et al. | Sensitive quantitation of ESR1 mutations in cell-free DNA from breast cancer patients using base-specific invasive reaction assisted qPCR | |
| CN109355362B (zh) | 一种高灵敏的SNPs检测体系及应用 | |
| WO2022010917A1 (en) | Methods, compositions, and systems for detecting pnpla3 allelic variants | |
| JP5570657B2 (ja) | 遺伝子存在量の測定方法 | |
| CN110616261A (zh) | 一种用于检测egfr基因t790m突变的试剂盒及检测方法 | |
| WO2004092415A1 (ja) | ミトコンドリアｄｎａ３２４３変異の検出法および定量法ならびにそのためのキット | |
| JP5860667B2 (ja) | Ｅｇｆｒエクソン２１ｌ８５８ｒ遺伝子多型検出用プライマーセット及びその用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110516 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110516 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130528 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20130710 Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130710 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140318 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20140514 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20140722 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140729 |
|
| R151 | Written notification of patent or utility model registration |
Ref document number: 5590781 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R151 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |